Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMA OFFICINE PHARMA L ALLIANCE : revenue, balance sheet and financial ratios

SELARL PHARMA OFFICINE PHARMA L ALLIANCE is a French company founded 29 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in TOUL (54200), this company of category PME shows in 2024 a net income negative of -3 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMA OFFICINE PHARMA L ALLIANCE (SIREN 410142798)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income -3 273 € -808 € 54 432 € 115 502 € 25 599 € 36 449 € 6 183 € 1 575 € 8 765 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SELARL PHARMA OFFICINE PHARMA L ALLIANCE records a net loss of 3 k€. This deficit will reduce equity on the balance sheet.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-3 273 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 6%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 80%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

5.635%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

80.054%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

13.2%

Solvency indicators evolution
SELARL PHARMA OFFICINE PHARMA L ALLIANCE

Sector positioning

Debt ratio
5.63 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent

In 2024, the debt ratio of SELARL PHARMA OFFICINE PH... (5.63) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
80.05% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent +6 pts over 3 years

In 2024, the financial autonomy of SELARL PHARMA OFFICINE PH... (80.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 260.45. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

260.455

Liquidity indicators evolution
SELARL PHARMA OFFICINE PHARMA L ALLIANCE

Sector positioning

Liquidity ratio
260.45 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good +8 pts over 3 years

In 2024, the liquidity ratio of SELARL PHARMA OFFICINE PH... (260.45) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of SELARL PHARMA OFFICINE PHARMA L ALLIANCE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMA OFFICINE PHARMA L ALLIANCE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMA OFFICINE PHARMA L ALLIANCE

What is the revenue of SELARL PHARMA OFFICINE PHARMA L ALLIANCE ?

The revenue of SELARL PHARMA OFFICINE PHARMA L ALLIANCE is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMA OFFICINE PHARMA L ALLIANCE profitable?

SELARL PHARMA OFFICINE PHARMA L ALLIANCE recorded a net loss in 2024.

Where is the headquarters of SELARL PHARMA OFFICINE PHARMA L ALLIANCE ?

The headquarters of SELARL PHARMA OFFICINE PHARMA L ALLIANCE is located in TOUL (54200), in the department Meurthe-et-Moselle.

Where to find the tax return of SELARL PHARMA OFFICINE PHARMA L ALLIANCE ?

The tax return of SELARL PHARMA OFFICINE PHARMA L ALLIANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMA OFFICINE PHARMA L ALLIANCE operate?

SELARL PHARMA OFFICINE PHARMA L ALLIANCE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.